Close

Today's Most Important Initiations

October 18, 2022 5:31 PM EDT Send to a Friend
Raymond James initiated coverage on Xenon Pharmaceuticals (NASDAQ: XENE) with an Outperform rating and a price target of $52.00. Shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login